These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21067368)

  • 1. Acute hepatitis C virus infection: a dynamic-and challenging-concept.
    Irving WL; Brown RJ
    J Infect Dis; 2010 Dec; 202(12):1765-7. PubMed ID: 21067368
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic coinfection with multiple viral subtypes in acute hepatitis C.
    Smith JA; Aberle JH; Fleming VM; Ferenci P; Thomson EC; Karayiannis P; McLean AR; Holzmann H; Klenerman P
    J Infect Dis; 2010 Dec; 202(12):1770-9. PubMed ID: 21067369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of HIV on host-virus interactions during early hepatitis C virus infection.
    Danta M; Semmo N; Fabris P; Brown D; Pybus OG; Sabin CA; Bhagani S; Emery VC; Dusheiko GM; Klenerman P
    J Infect Dis; 2008 Jun; 197(11):1558-66. PubMed ID: 18419344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV and interferon: viral strategies for evading innate defence mechanisms in the virus-host battle.
    Capobianchi MR; Abbate I; Cappiello G; Solmone M
    Cell Death Differ; 2003 Jan; 10 Suppl 1():S22-4. PubMed ID: 12655342
    [No Abstract]   [Full Text] [Related]  

  • 5. [Distribution of hepatitis C virus genotype in Dalian].
    Xie Y; Xie C
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):872-3. PubMed ID: 19958651
    [No Abstract]   [Full Text] [Related]  

  • 6. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
    Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
    Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview about hepatitis C: a devastating virus.
    Bostan N; Mahmood T
    Crit Rev Microbiol; 2010 May; 36(2):91-133. PubMed ID: 20345213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of virologic assays in the diagnosis and management of hepatitis C virus infection.
    Chevaliez S; Pawlotsky JM
    Clin Liver Dis; 2005 Aug; 9(3):371-82, v. PubMed ID: 16023971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of hepatitis C virus (HCV) genotypes among HCV infection risk groups in Lebanon.
    Makhoul NJ; Choueiri MB; Kattar MM; Soweid AM; Shamseddeen W; Estephan HC; Khalife J; Haddad A; Abi Rached A; Zalloua PA
    J Clin Virol; 2008 Feb; 41(2):166-7. PubMed ID: 18054277
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies.
    Moreira R; Pinho JR; Fares J; Oba IT; Cardoso MR; Saraceni CP; Granato C
    Can J Microbiol; 2003 Aug; 49(8):503-7. PubMed ID: 14608385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C: molecular biology, pathogenesis, epidemiology, clinical features, and prevention.
    Esteban JI; Genesca J; Alter HJ
    Prog Liver Dis; 1992; 10():253-82. PubMed ID: 1338348
    [No Abstract]   [Full Text] [Related]  

  • 12. The discovery of the NANB hepatitis virus by gene technology.
    Decker RH
    Beitr Infusionsther; 1992; 30():6-12. PubMed ID: 1284768
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic hepatitis C--clinical course and genotypical pattern of distribution in patients of a Berlin infection clinic].
    Baumgarten R; Fengler JD; Roschke I; Schreier E
    Z Arztl Fortbild (Jena); 1994 Oct; 88(10):793-6. PubMed ID: 7825360
    [No Abstract]   [Full Text] [Related]  

  • 14. [Viral hepatitis C].
    Zeuzem S; Roth WK; Herrmann G
    Z Gastroenterol; 1995 Feb; 33(2):117-32. PubMed ID: 7536996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seronegative hepatitis C virus infection, not just RNA detection.
    Stapleton JT; Schmidt WN; Katz L
    J Infect Dis; 2004 Aug; 190(3):651-2. PubMed ID: 15243946
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C.
    Hwang SJ; Lee SD; Lu RH; Chu CW; Wu JC; Lai ST; Chang FY
    J Med Virol; 2001 Nov; 65(3):505-9. PubMed ID: 11596085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C.
    PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR
    Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New natural intergenotypic (2/5) recombinant of hepatitis C virus.
    Legrand-Abravanel F; Claudinon J; Nicot F; Dubois M; Chapuy-Regaud S; Sandres-Saune K; Pasquier C; Izopet J
    J Virol; 2007 Apr; 81(8):4357-62. PubMed ID: 17267503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection.
    Higashi K; Tsukiyama-Kohara K; Tanaka T; Tanaka E; Kiyosawa K; Kohara M
    Arch Virol; 2005 May; 150(5):883-98. PubMed ID: 15662481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evasion of intracellular host defence by hepatitis C virus.
    Gale M; Foy EM
    Nature; 2005 Aug; 436(7053):939-45. PubMed ID: 16107833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.